BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25987041)

  • 21. Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
    Chiu HW; Ho YS; Wang YJ
    J Mol Med (Berl); 2011 Sep; 89(9):927-41. PubMed ID: 21594580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
    Wang Y; An R; Dong X; Pan S; Duan G; Sun X
    Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
    Zhao XS; Song PL; Sun B; Jiang HC; Liu TF
    Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma.
    Lam SK; Li YY; Zheng CY; Ho JC
    Int J Oncol; 2015 Jan; 46(1):113-22. PubMed ID: 25335113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells.
    Chiu HW; Tseng YC; Hsu YH; Lin YF; Foo NP; Guo HR; Wang YJ
    Cancer Lett; 2015 Jan; 356(2 Pt B):762-72. PubMed ID: 25449439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform.
    Mesbahi Y; Zekri A; Ahmadian S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Eur J Pharmacol; 2018 Feb; 820():274-285. PubMed ID: 29274334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E3 ubiquitin ligase Cbl-b potentiates the apoptotic action of arsenic trioxide by inhibiting the PI3K/Akt pathway.
    Yingchun L; Xiujuan Q; Jinglei Q; Ye Z; Jing L; Yuee T; Xuejun H; Kezuo H; Yunpeng L
    Braz J Med Biol Res; 2011 Feb; 44(2):105-11. PubMed ID: 21180886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer.
    Chang YW; Chen MW; Chiu CF; Hong CC; Cheng CC; Hsiao M; Chen CA; Wei LH; Su JL
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S687-95. PubMed ID: 25047463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
    J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
    Du S; Liu K; Gao P; Li Z; Zheng J
    Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
    Boyko-Fabian M; Niehr F; Distel L; Budach V; Tinhofer I
    PLoS One; 2014; 9(6):e98867. PubMed ID: 24927258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arsenic trioxide inhibits growth of human chondrosarcoma cells through G2/M arrest and apoptosis as well as autophagy.
    Jiao G; Ren T; Guo W; Ren C; Yang K
    Tumour Biol; 2015 May; 36(5):3969-77. PubMed ID: 25577250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
    Shen L; Zhang G; Lou Z; Xu G; Zhang G
    BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.
    Bao X; Ren T; Huang Y; Wang S; Zhang F; Liu K; Zheng B; Guo W
    J Exp Clin Cancer Res; 2016 Aug; 35(1):129. PubMed ID: 27576314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH.
    Han YH; Kim SZ; Kim SH; Park WH
    Cancer Lett; 2008 Oct; 270(1):40-55. PubMed ID: 18539383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth.
    Jutooru I; Chadalapaka G; Sreevalsan S; Lei P; Barhoumi R; Burghardt R; Safe S
    Exp Cell Res; 2010 Aug; 316(13):2174-88. PubMed ID: 20435036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.
    Wei LH; Lai KP; Chen CA; Cheng CH; Huang YJ; Chou CH; Kuo ML; Hsieh CY
    Oncogene; 2005 Jan; 24(3):390-8. PubMed ID: 15531921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of arsenic trioxide alone and in combination with bortezomib in multiple myeloma RPMI 8266 cells.
    Elmahi AY; Niu C; Li W; Li D; Wang GJ; Hao SS; Cui JW
    Asian Pac J Cancer Prev; 2013; 14(11):6469-73. PubMed ID: 24377552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic trioxide exerts a double effect on osteoblast growth in vitro.
    Xu WX; Liu Y; Liu SZ; Zhang Y; Qiao GF; Yan J
    Environ Toxicol Pharmacol; 2014 Sep; 38(2):412-9. PubMed ID: 25128771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arsenic trioxide inhibits proliferation and induces apoptosis in pancreatic cancer cells.
    Li X; Ding X; Adrian TE
    Anticancer Res; 2002; 22(4):2205-13. PubMed ID: 12174905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.